In this context, we should recall that our group has recently reported a correlation between selective faah gene expression alteration and DNA methylation in Alzheimer's disease patients [28], highlighting how epigenetic studies might be helpful in the identification of new therapeutic targets within the endocannabinoid system. The gene discussed is FAAH; the disease is early-onset autosomal dominant Alzheimer disease.